HYBRID EVENT: You can participate in person at London, UK or Virtually from your home or work.

5th Edition of Euro-Global Conference on Biotechnology and Bioengineering

September 18-20 | Hybrid Event

September 18-20, 2025 | London, UK

Vaccine Development & Immunotechnology

Vaccine Development & Immunotechnology

Accelerated by global health demands, vaccine development & immunotechnology focuses on engineering immune-based solutions that protect against infectious diseases and chronic conditions. This field brings together antigen design, adjuvant innovation, and delivery platform development—ranging from recombinant proteins and viral vectors to mRNA technologies. Cutting-edge immunotechnology supports the creation of more stable, targeted, and long-lasting vaccines, while nanotechnology and liposomal carriers enhance delivery efficiency. In addition, bioinformatics tools are aiding epitope prediction and immune profiling. Vaccine Development & Immunotechnology also contributes to therapeutic vaccines against cancer, autoimmune disorders, and allergies. As rapid-response vaccine platforms become more robust, this area remains critical for ensuring global health preparedness, equitable distribution, and next-generation immunization strategies.

Committee Members
Speaker at Biotechnology and Bioengineering 2025 - Thomas J Webster

Thomas J Webster

Interstellar Therapeutics, United States
Speaker at Biotechnology and Bioengineering 2025 - Steve Busby

Steve Busby

University of Birmingham, United Kingdom
Speaker at Biotechnology and Bioengineering 2025 - Murray Moo Young

Murray Moo Young

University of Waterloo, Canada
ECBB 2025 Speakers
Speaker at Biotechnology and Bioengineering 2025 - Julia Sidorova

Julia Sidorova

Centro de Investigación Biomédica En Red Enfermedades Hepáticas y Digestivas (CIBEREHD), Spain
Speaker at Biotechnology and Bioengineering 2025 - Luis Jesus Villarreal Gomez

Luis Jesus Villarreal Gomez

Universidad Autonoma de Baja California, Mexico
Speaker at Biotechnology and Bioengineering 2025 - Assad Al Ammar

Assad Al Ammar

Specialty Enzymes and Probiotics, United States
Speaker at Biotechnology and Bioengineering 2025 - Tina Moller Tagmose

Tina Moller Tagmose

Novo Nordisk A/S, Denmark
Tags

Submit your abstract Today

Watsapp
a